Home/Filings/4/0001628280-25-053859
4//SEC Filing

Stanton Marshall S. 4

Accession 0001628280-25-053859

CIK 0000784199other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 5:23 PM ET

Size

17.3 KB

Accession

0001628280-25-053859

Insider Transaction Report

Form 4
Period: 2025-11-21
Stanton Marshall S.
SVP, Clinical & MD Affair
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-21$18.44/sh+20,301$374,35065,054 total
  • Sale

    Common Stock

    2025-11-21$45.35/sh5,715$259,15244,753 total
  • Sale

    Common Stock

    2025-11-21$44.91/sh18,705$840,04253,123 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-11-2120,3010 total
    Exercise: $18.44From: 2023-02-23Exp: 2029-02-23Common Stock (20,301 underlying)
  • Sale

    Common Stock

    2025-11-21$44.92/sh14,586$655,18950,468 total
  • Exercise/Conversion

    Common Stock

    2025-11-21$11.03/sh+27,075$298,63771,828 total
  • Sale

    Common Stock

    2025-11-21$45.34/sh8,370$379,53844,753 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-11-2127,0750 total
    Exercise: $11.03From: 2023-11-08Exp: 2029-11-08Common Stock (27,075 underlying)
Footnotes (6)
  • [F1]Reflects weighted average price. Range of prices were between $44.26 to $45.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]Reflects weighted average price. Range of prices were between $45.26 to $45.54. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Reflects weighted average price. Range of prices were between $44.26 to $45.255. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Reflects weighted average price. Range of prices were between $45.26 to $45.53. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023.
  • [F6]Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

Issuer

ARTIVION, INC.

CIK 0000784199

Entity typeother

Related Parties

1
  • filerCIK 0001849615

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 5:23 PM ET
Size
17.3 KB